These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 35726302)

  • 1. Serum IMA and LP-PLA2 Levels in Patients with Coronary Heart Disease and Their Correlation with the Degree of Myocardial Ischaemia and Their Diagnostic Value.
    Zhang L; Li Z; Li N
    Emerg Med Int; 2022; 2022():1698315. PubMed ID: 35726302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of serum lipoprotein-associated phospholipase A2, ischemia-modified albumin, and cystatin C in predicting coronary heart disease risk: a single center retrospective cohort study.
    Le QF; Liu J; Chen L
    Eur Rev Med Pharmacol Sci; 2023 Nov; 27(21):10730-10735. PubMed ID: 37975398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of Serum CysC, IMA, and LP-PLA2 Levels With Type 2 Diabetes Mellitus Patients With Lower Extremity Atherosclerotic Occlusive Disease.
    Feng F; Chen Y; Wang G; Huang P; Zhu Q; Zhou B
    Front Surg; 2022; 9():846470. PubMed ID: 35356504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Correlation between serum inflammatory cytokine levels and fibrous cap thickness of fibrofatty plaque in coronary culprit lesions].
    Zhong Y; Ye F; You W; Wu ZM
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jul; 45(7):566-571. PubMed ID: 28738484
    [No Abstract]   [Full Text] [Related]  

  • 5. Study on the correlation between the concentration of plasma lipoprotein-associated phospholipase A2 and coronary heart disease.
    Cen JM; Cheng J; Xiong QY; Mei BQ; Cai WB; Yang XL
    Chronic Dis Transl Med; 2015 Jun; 1(2):105-109. PubMed ID: 29062994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between serum lipoprotein-associated phospholipase A2, ischemic modified albumin and acute coronary syndrome: a cross-sectional study.
    Yang F; Ma L; Zhang L; Wang Y; Zhao C; Zhu W; Liang W; Liu Q
    Heart Vessels; 2019 Oct; 34(10):1608-1614. PubMed ID: 30963302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Change of Inflammatory Factors in Patients with Acute Coronary Syndrome.
    Ma CY; Xu ZY; Wang SP; Peng HY; Liu F; Liu JH; Ren FX
    Chin Med J (Engl); 2018 Jun; 131(12):1444-1449. PubMed ID: 29893361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homocysteine and Lp-PLA2 levels: Diagnostic value in coronary heart disease.
    Wu L; Shao P; Gao Z; Zhang S; Ma J; Bai J; Wei Y
    Medicine (Baltimore); 2023 Nov; 102(46):e35982. PubMed ID: 37986337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The expression and prognostic value of ischemia modified albumin (IMA), red blood cell distribution width (RDW), and lipoprotein (LP) in patients with diabetes mellitus complicated with coronary heart disease.
    Xiang L; Zhang M; Wu H; Xie D
    Ann Palliat Med; 2021 Apr; 10(4):4463-4471. PubMed ID: 33894715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated Lipoprotein-Associated Phospholipase A2 is Valuable in Prediction of Coronary Slow Flow in Non-ST-Segment Elevation Myocardial Infarction Patients.
    Liang Q; Lei X; Huang X; Fan L; Yu H
    Curr Probl Cardiol; 2021 Mar; 46(3):100596. PubMed ID: 32444159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Utility of the Serum Level of Lipoprotein-Related Phospholipase A2 in Acute Ischemic Stroke With Cerebral Artery Stenosis.
    Cao J; Yan P; Zhou Y; Zhou X; Sun Z; Zhu XQ
    Front Neurol; 2021; 12():642483. PubMed ID: 33746893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of lipoprotein-associated phospholipase A2(Lp-PLA2) and periprocedural myocardial injury in patients undergoing elective percutaneous coronary intervention.
    Yin YJ; Chen YC; Xu L; Zhao XH; Song Yang
    Int J Cardiol Heart Vasc; 2020 Jun; 28():100541. PubMed ID: 32490148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic Effect of Lipoprotein-Associated Phospholipase A2 with Classical Risk Factors on Coronary Heart Disease: A Multi-Ethnic Study in China.
    Ge PC; Chen ZH; Pan RY; Ding XQ; Liu JY; Jia QW; Liu Z; He SZ; An FH; Li LH; Li ZY; Gu Y; Zhu TB; Li CJ; Wang LS; Ma WZ; Yang ZJ; Jia EZ
    Cell Physiol Biochem; 2016; 40(5):953-968. PubMed ID: 27941334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relationship between serum levels of osteoproteins, inflammatory cytokines and coronary heart disease and disease severity].
    Zhao F; Zhang R; Zhao H; Liu T; Ren M; Song Y; Liu S; Cong H
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 May; 31(5):588-593. PubMed ID: 31198145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoprotein-Associated Phospholipase A2 in Cardiac Disease: a Potential Early Biomarker of Unstable Coronary Artery Disease.
    Li J; Zhou Z; Niu X; Li H
    Clin Lab; 2020 May; 66(5):. PubMed ID: 32390386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of Long Non-coding RNA LncRNA-FA2H-2 With Inflammatory Markers in the Peripheral Blood of Patients With Coronary Heart Disease.
    Guo F; Sha Y; Hu B; Li G
    Front Cardiovasc Med; 2021; 8():682959. PubMed ID: 34235188
    [No Abstract]   [Full Text] [Related]  

  • 17. Association between Lp-PLA2 and coronary heart disease in Chinese patients.
    Yang L; Liu Y; Wang S; Liu T; Cong H
    J Int Med Res; 2017 Feb; 45(1):159-169. PubMed ID: 28222638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating Oxidized Low-Density Lipoprotein is a Strong Risk Factor for the Early Stage of Coronary Heart Disease.
    Zhang Q; Ai Y; Dong H; Wang J; Xu L
    IUBMB Life; 2019 Feb; 71(2):277-282. PubMed ID: 30414358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Diagnostic Value of Combined Detection of Serum Lp-PLA2 and Hcy and Color Doppler in Elderly Patients with Acute Coronary Syndrome and Effect on Endothelial Function.
    Zhao L; Qi J; Luo F; Zhao N
    Evid Based Complement Alternat Med; 2022; 2022():3150670. PubMed ID: 35845603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ischemia-modified albumin in stable coronary atherosclerotic heart disease: clinical diagnosis and risk stratification.
    Zhong Y; Wang N; Xu H; Hou X; Xu P; Zhou Z
    Coron Artery Dis; 2012 Dec; 23(8):538-41. PubMed ID: 22936021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.